PE
THC icon

Point72 Europe’s Tenet Healthcare THC Stock Holding History

Point72 Europe’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$195K Buy
+962
New +$171K 0.01% 201

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Point72 Europe's THC Position: Q3 2025 in Review

Point72 Europe opened a new position in Tenet Healthcare (THC) in Q3 2025: 962 shares worth $195K. The stake represents 0.01% of the portfolio and ranks #201 among its holdings.

680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Point72 Europe held 962 shares of Tenet Healthcare worth $195K as of Q3 2025.
  • Tenet Healthcare was a new Point72 Europe position in Q3 2025.
  • Tenet Healthcare made up 0.01% of Point72 Europe's portfolio in Q3 2025, its #201 holding.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.